Home
About Us
Group Profile
Where we Operate
Board of Directors
Corporate Social Responsibility
Our People
Our Divisions
Healthcare Supply Chain
Sales, Marketing & Medical
Packaging and Specialty
Investor Centre
United Drug at a Glance
Financial Highlights
Results and Reporting
Corporate Governance
News and Events
Investor Services
News
Contact Us
Search
Search United Drug
Search
Investor Centre
ISE (Dublin)
LSE (London)
€2.27
0.01
181.50p
0.00
United Drug at a Glance
Structure
Where we operate
Financial Highlights
Financial Highlights
Group Income Statement
Group Balance Sheet
Group Cashflow Statement
Performance by Division
Other Information
Results and Reporting
Latest Update
Annual Report
Preliminary Results
Interim Results
Webcasts and Presentations
Corporate Governance
Directors' Statement on Corporate Governance from 2011 Annual Report
Board of Directors
Terms of Reference
News and Events
RNS & Filings
Press Releases
Annual Information Update
Investor Services
Investor Fraud
AGM
Share Price & Share Chart
Dividend Information
Analyst Coverage
FAQ's
Contact Details
Investor Calendar
Shareholder Forms
Dividend Reinvestment Plan
Home
>
Investor Centre
>
Group Income Statement
Bookmark
Email
Print Page
United Drug at a Glance
Structure
Where we operate
Structure
Financial Highlights
Financial Highlights
Group Income Statement
Group Balance Sheet
Group Cashflow Statement
Performance by Division
Other Information
Financial Highlights
Results and Reporting
Latest Update
Annual Report
Preliminary Results
Interim Results
Webcasts and Presentations
2012
Latest Update
Corporate Governance
Directors' Statement on Corporate Governance from 2011 Annual Report
Board of Directors
Terms of Reference
Directors' Statement on Corporate Governance from 2011 Annual Report
News and Events
RNS & Filings
Press Releases
Annual Information Update
RNS & Filings
Investor Services
Investor Fraud
AGM
Share Price & Share Chart
LSE History Download
Dividend Information
Analyst Coverage
FAQ's
Contact Details
Advisor Details & PR Contacts
Investor Calendar
Shareholder Forms
Company Registrar
Dividend Reinvestment Plan
Email Alerts
Edit Email Alerts
Investor Fraud
Read our Annual Report
Read United Drug's 2011 Annual Report online detailing the company's performance and financial results.
Group Income Statement
Group Income Statement year ended 30 September
2011*
2010
2009*
2008
2007
€' 000
€' 000
€' 000
€' 000
€' 000
Revenue
1,746,452
1,726,066
1,717,937
1,683,712
1,583,622
Cost of Sales
(1,470,014)
(1,458,972)
(1,452,585)
(1,423,978)
(1,352,186)
Gross Profit
276,438
267,094
265,352
259,734
231,436
Distribution expenses
(193,381)
(187,118)
(184,950)
(178,185)
(161,617)
Administrative expenses
(7,405)
(7,792)
(6,732)
(6,741)
(6,372)
Other operating expenses
(14,534)
(13,180)
(13,853)
(11,977)
(6,554)
Share of joint ventures' profit after tax
1,134
1,951
3,088
3,389
3,145
Operating Profit
62,252
60,955
62,905
66,220
60,038
Finance Income
8,322
10,250
3,433
3,121
1,156
Finance Expense
(16,657)
(16,766)
(13,266)
(10,790)
(5,821)
Profit Before Tax
53,917
54,439
53,072
58,551
55,773
Income Tax Expense
(9,699)
(9,796)
(8,618)
(8,346)
(8,443)
Profit for the financial year
44,218
44,643
44,454
50,205
47,330
Earnings Per Share
basic (cent)
15.10
18.70
14.24
21.81
20.96
diluted (cent)
15.05
18.67
14.22
21.61
20.81
Adjusted basic (cent)
22.89
22.84
23.45
25.93
23.19
Adjusted diluted (cent)
22.81
22.80
23.42
25.70
23.02
dividend per share (cent)
8.88
8.40
8.00
8.00
7.30
Interest cover (times)
11.0
13.6
9.2
10.2
15.6
* before Exceptional Item